Aldeyra Therapeutics Schedules Webcast & Conference Call to Report Full-Year 2020 Financial Results & Discuss Recent Bus. Hig...
March 04 2021 - 8:00AM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a
conference call at 8:00 a.m. ET Thursday, March 11, 2021 to report
financial results for the year ended December 31, 2020 and discuss
recent business highlights.
The dial-in numbers are (866) 211-4098 for domestic callers and
(647) 689-6613 for international callers. The Conference ID number
is 6253616. A live webcast of the conference call will also be
available on the Investors & Media page of the company’s
corporate website at https://ir.aldeyra.com.
After the live webcast, the event will remain archived on the
Aldeyra Therapeutics website for 90 days.
About Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics is a clinical-stage biotechnology company
focused on the development of novel therapies with the potential to
improve the lives of patients with immune-mediated diseases. Two of
the company’s lead investigational compounds, reproxalap and
ADX-629, target RASP (reactive aldehyde species), which are
elevated in ocular and systemic inflammatory disease and result in
cytokine release via activation of a broad array of inflammatory
factors, including NF-κB, inflammasomes, and Scavenger Receptor A.
Reproxalap is being evaluated in Phase 3 clinical trials in
patients with dry eye disease and allergic conjunctivitis. The
company’s clinical pipeline also includes ADX-2191, a dihydrofolate
reductase inhibitor in Phase 3 testing for proliferative
vitreoretinopathy, and ADX-1612, a chaperome inhibitor in
development for COVID-19 and ovarian cancer. For more information,
visit https://www.aldeyra.com/ and follow us on LinkedIn, Facebook,
and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210304005055/en/
Corporate Contact: Joshua Reed Aldeyra Therapeutics, Inc.
Tel: 781-761-4904 ext. 218 jreed@aldeyra.com Investor &
Media Contact: Scott Solomon Sharon Merrill Associates, Inc.
Tel: 617-542-5300 ALDX@investorrelations.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024